Prestige Consumer Healthcare, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
284.00
276.00
-93.00
262.00
204.00
191.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-41.00
-39.00
-53.00
-10.00
-5.00
8.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
251.00
248.00
229.00
259.00
235.00
217.00
Cash Flow from Investing Activities
-17.00
-20.00
-11.00
-256.00
-22.00
-16.00
Cash Flow from Financing Activities
-182.00
-241.00
-185.00
-7.00
-279.00
-131.00
Net Cash Inflow / Outflow
51.00
-12.00
31.00
-5.00
-62.00
67.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
3.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Prestige Consumer Healthcare, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
284.189
0
284.00
0.00%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-41.941
0
-41.00
0.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
251.515
0
251.00
0.00%
Cash Flow from Investing Activities
-17.452
0
-17.00
0.00%
Cash Flow from Financing Activities
-182.075
0
-182.00
0.00%
Net Cash Inflow / Outflow
51.415
0
51.00
0.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.573
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 1.04% vs 8.36% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
251.51
248.93
1.04%






